Freestone Grove Partners LP Acquires New Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Freestone Grove Partners LP bought a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 43,337 shares of the company's stock, valued at approximately $299,000. Freestone Grove Partners LP owned about 0.09% of Nu Skin Enterprises at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Susquehanna International Group LLP raised its position in shares of Nu Skin Enterprises by 191.9% during the 4th quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock worth $4,838,000 after purchasing an additional 461,608 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Nu Skin Enterprises by 74.9% in the fourth quarter. JPMorgan Chase & Co. now owns 405,667 shares of the company's stock valued at $2,795,000 after acquiring an additional 173,710 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Nu Skin Enterprises by 18.5% during the fourth quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company's stock valued at $4,226,000 after acquiring an additional 95,938 shares during the last quarter. American Century Companies Inc. increased its position in Nu Skin Enterprises by 12.0% during the 4th quarter. American Century Companies Inc. now owns 824,739 shares of the company's stock worth $5,682,000 after purchasing an additional 88,181 shares in the last quarter. Finally, AlphaQuest LLC raised its stake in Nu Skin Enterprises by 197.8% in the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company's stock valued at $746,000 after purchasing an additional 71,864 shares during the last quarter. Hedge funds and other institutional investors own 82.84% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a report on Tuesday, April 8th.

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS opened at $6.17 on Monday. The business has a fifty day simple moving average of $6.90 and a 200-day simple moving average of $6.95. Nu Skin Enterprises, Inc. has a 52 week low of $5.32 and a 52 week high of $14.00. The company has a market cap of $306.79 million, a P/E ratio of -2.09 and a beta of 1.10. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The business had revenue of $445.55 million for the quarter, compared to analyst estimates of $441.10 million. Equities research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 3.89%. The ex-dividend date was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio is currently -8.14%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.